360 related articles for article (PubMed ID: 17350145)
1. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
Sylte MJ; Hubby B; Suarez DL
Vaccine; 2007 May; 25(19):3763-72. PubMed ID: 17350145
[TBL] [Abstract][Full Text] [Related]
2. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
4. Prior infection of chickens with H1N1 avian influenza virus elicits heterologous protection against highly pathogenic H5N2.
Nfon C; Berhane Y; Pasick J; Kobinger G; Kobasa D; Babiuk S
Vaccine; 2012 Nov; 30(50):7187-92. PubMed ID: 23084852
[TBL] [Abstract][Full Text] [Related]
5. Development and use of fowlpox vectored vaccines for avian influenza.
Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
[TBL] [Abstract][Full Text] [Related]
6. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
[TBL] [Abstract][Full Text] [Related]
7. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
Lee CW; Senne DA; Suarez DL
Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
[TBL] [Abstract][Full Text] [Related]
8. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
[TBL] [Abstract][Full Text] [Related]
9. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
[TBL] [Abstract][Full Text] [Related]
10. Priming with a DNA vaccine delivered by attenuated Salmonella typhimurium and boosting with a killed vaccine confers protection of chickens against infection with the H9 subtype of avian influenza virus.
Pan Z; Zhang X; Geng S; Cheng N; Sun L; Liu B; Huang J; Jiao X
Vaccine; 2009 Feb; 27(7):1018-23. PubMed ID: 19103246
[TBL] [Abstract][Full Text] [Related]
11. Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
Pushko P; Tretyakova I; Hidajat R; Zsak A; Chrzastek K; Tumpey TM; Kapczynski DR
Virology; 2017 Jan; 501():176-182. PubMed ID: 27936463
[TBL] [Abstract][Full Text] [Related]
12. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
[TBL] [Abstract][Full Text] [Related]
13. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
Beard CW; Schnitzlein WM; Tripathy DN
Avian Dis; 1991; 35(2):356-9. PubMed ID: 1649592
[TBL] [Abstract][Full Text] [Related]
14. [Construction, genetic stability and protective efficacy of recombinant fowlpox virus expressing hemagglutinin gene of H5N1 subtype avian influenza virus].
Jia L; Peng D; Zhang Y; Liu H; Liu X
Wei Sheng Wu Xue Bao; 2003 Dec; 43(6):722-7. PubMed ID: 16276892
[TBL] [Abstract][Full Text] [Related]
15. Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus.
Swayne DE; Lee CW; Spackman E
Avian Pathol; 2006 Apr; 35(2):141-6. PubMed ID: 16595307
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for List A poultry diseases: emphasis on avian influenza.
Swayne DE
Dev Biol (Basel); 2003; 114():201-12. PubMed ID: 14677690
[TBL] [Abstract][Full Text] [Related]
17. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/1370/83 infection.
Wood JM; Kawaoka Y; Newberry LA; Bordwell E; Webster RG
Avian Dis; 1985; 29(3):867-72. PubMed ID: 4074253
[TBL] [Abstract][Full Text] [Related]
18. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.
Worrall EE; Sudarisman ; Priadi A
Vaccine; 2009 Jun; 27(31):4161-8. PubMed ID: 19406183
[TBL] [Abstract][Full Text] [Related]
19. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.
Swayne DE; Beck JR; Kinney N
Avian Dis; 2000; 44(1):132-7. PubMed ID: 10737653
[TBL] [Abstract][Full Text] [Related]
20. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens.
Li C; Ping J; Jing B; Deng G; Jiang Y; Li Y; Tian G; Yu K; Bu Z; Chen H
Biochem Biophys Res Commun; 2008 Jul; 372(2):293-7. PubMed ID: 18501701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
